Tab Application Banner
  • Users Online: 1138
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2019| March  | Volume 14 | Issue 1  
    Online since March 14, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
CASE-BASED REVIEW
Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient
Debashish Mishra, Shefali Khanna Sharma, Aman Sharma, Sanjay Jain, Varun Dhir
March 2019, 14(1):61-64
DOI:10.4103/injr.injr_127_18  
  2 4,382 190
ORIGINAL ARTICLES
Prescribing patterns and safety of biologics in immune-mediated rheumatic diseases: Karnataka biologics cohort study group experience
Vineeta Shobha, Vijay Rao, Anu Mohan Desai, Ramesh Jois, Chandrashekara Srikantiah, BG Dharmanand, Sharath Kumar, Pradeep Kumar, Chethana Dharmapalaiah, KM Mahendranath, Shiva Prasad, Manisha Daware, Yogesh Singh, Uma Karjigi
March 2019, 14(1):17-20
DOI:10.4103/injr.injr_79_18  
  2 3,066 211
CASE-BASED REVIEW
Childhood polyarteritis nodosa presenting as central nervous system vasculitis
Sham Santhanam, Ravikumar Thambithurai, Nataraj Palaniappan, Mukul Vij, Srinivasan Kalyanasundaram
March 2019, 14(1):65-68
DOI:10.4103/injr.injr_129_18  
  1 3,010 160
FROM THE EDITORS DESK
But I Have Promises to Keep……
Vikas Agarwal
March 2019, 14(1):1-1
DOI:10.4103/0973-3698.254212  
  1 2,491 254
ORIGINAL ARTICLES
Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
Ekbote Gayatri, Tanna Dhaval, Negalur Natasha, Bindroo Muzaffar, Raval Dhiren, Sharma Lucky, Rajiva Gupta
March 2019, 14(1):12-16
DOI:10.4103/injr.injr_138_18  
  1 2,884 249
Serum sclerostin levels in rheumatoid arthritis and correlation with disease activity and bone mineral density
Urmila Dhakad, Rasmi Ranjan Sahoo, Akhil Pawan Goel, Sourav Pradhan, Ragini Srivastava, Siddharth Kumar Das
March 2019, 14(1):28-31
DOI:10.4103/injr.injr_113_18  
  1 2,755 157
A cross-sectional study of different rheumatic diseases and their respective comorbidities at a tertiary care hospital in India
Baikan Saiteja Yadav, Arindam Nandy Roy, Syeda Sana Fatima
March 2019, 14(1):42-48
DOI:10.4103/injr.injr_112_18  
  1 3,759 290
CASE-BASED REVIEW
Livedoid vasculopathy with mononeuritis multiplex associated with protein S deficiency mimicking systemic vasculitis
Vikramraj K Jain, Krishnamurthy Hegde, Renuka Panchagnula
March 2019, 14(1):69-73
DOI:10.4103/injr.injr_97_18  
  - 2,947 153
Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
Rahul Reddy, Anu Punnen, Annie Bella, Sathish Kumar
March 2019, 14(1):74-76
DOI:10.4103/injr.injr_118_18  
  - 3,109 181
EDITORIALS
Advanced therapies for inflammatory rheumatic diseases in resource-poor settings
Vinod Chandran
March 2019, 14(1):7-8
DOI:10.4103/0973-3698.254191  
  - 2,905 200
Challenges in assessing the disease activity of takayasu arteritis
Durga Prasanna Misra, Anupam Wakhlu
March 2019, 14(1):2-3
DOI:10.4103/injr.injr_19_19  
  - 2,556 258
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
Saket Jha, GSRSNK Naidu, Aman Sharma
March 2019, 14(1):4-6
DOI:10.4103/0973-3698.254190  
  - 3,256 263
Utility of CD64 expression on neutrophils as a marker to differentiate infectious versus noninfectious disease flares in autoimmune disorders
Ashutosh K Mangalam, Rajwardhan Yadav
March 2019, 14(1):9-11
DOI:10.4103/0973-3698.254192  
  - 2,681 192
LETTERS TO EDITOR
No impact of seronegativity on the efficacy of a biosimilar rituximab in biologic-naïve patients with active rheumatoid arthritis
Nedumooli Pottammal Jamshid, Vinod Ravindran
March 2019, 14(1):77-78
DOI:10.4103/injr.injr_158_18  
  - 2,571 114
Use of coffee for alleviating methotrexate intolerance in rheumatic diseases
Anand Narayan Malaviya, Sadhana Singh Baghel, Shallu Verma, Ravita Thakran, Christy Messi
March 2019, 14(1):79-80
DOI:10.4103/injr.injr_144_18  
  - 3,041 178
A case of relapsing polychondritis with laryngeal stenosis successfully controlled with biosimilar adalimumab (ZRC-3197)
Manish Dugar, Jaswinder Singh Saluja, A Sudhakar
March 2019, 14(1):81-82
DOI:10.4103/injr.injr_111_18  
  - 2,434 141
Progressive pseudorheumatoid dysplasia: A mimicker of juvenile idiopathic arthritis
Sikha Agarwal, Anuja Pethe, Anuja Nayak
March 2019, 14(1):83-84
DOI:10.4103/injr.injr_132_18  
  - 2,637 133
OBITUARY
Obituary Prakash Pispati
Rohini Handa
March 2019, 14(1):85-86
DOI:10.4103/injr.injr_169_18  
  - 2,439 101
ORIGINAL ARTICLES
Pentraxin 3 is better than conventional inflammatory markers for disease activity assessment in takayasu arteritis
Phani Kumar Devarasetti, Rajendra Varaprasad Irlapati, Liza Rajasekhar
March 2019, 14(1):21-27
DOI:10.4103/injr.injr_95_18  
  - 2,833 163
Dual antibody status predicts sustained remission in patients with rheumatoid arthritis
Praveen Pratap Jadhav, Jaya Dilip Avhad, Mahendra Mahajan, Asmanaz Mehemud Patel, Hemant Ramchandra Gavli, Janhavee Praveen Jadhav, Vaibhav Khandelwal
March 2019, 14(1):32-36
DOI:10.4103/injr.injr_107_18  
  - 2,787 135
Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
Ashraf H Mohamed, Asmaa Enein, Noha Abdelsalam, Mona Balata, Sameh Abdellatif, Ehsan Rizk, Ahmed Fathy
March 2019, 14(1):37-41
DOI:10.4103/injr.injr_110_18  
  - 3,186 198
REVIEW ARTICLE
Management of pain in rheumatic diseases
Neha Goyal, Mohit Goyal, Vinod Ravindran
March 2019, 14(1):49-56
DOI:10.4103/injr.injr_88_18  
  - 3,396 257
TOPICAL REVIEW
Current treatment of osteoporosis
Subramanian Nallasivan
March 2019, 14(1):57-60
DOI:10.4103/injr.injr_74_18  
  - 6,202 677